Spire Healthcare Group (LON:SPI) Trading 9.1% Higher – Should You Buy?

Shares of Spire Healthcare Group plc (LON:SPI) traded up 9.1% during mid-day trading on Friday . The company traded as high as GBX 242.61 ($3.09) and last traded at GBX 239.50 ($3.05). 1,545,344 shares were traded during mid-day trading, an increase of 187% from the average session volume of 537,597 shares. The stock had previously closed at GBX 219.50 ($2.80).

Wall Street Analyst Weigh In

Separately, Berenberg Bank reissued a “buy” rating and issued a GBX 300 ($3.82) target price on shares of Spire Healthcare Group in a report on Tuesday, September 17th.

Spire Healthcare Group Price Performance

The stock’s 50 day simple moving average is GBX 223.86 and its 200 day simple moving average is GBX 239.38. The firm has a market capitalization of £918.69 million, a P/E ratio of 3,400.00, a P/E/G ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 169.51, a quick ratio of 0.74 and a current ratio of 0.70.

Insider Transactions at Spire Healthcare Group

In other Spire Healthcare Group news, insider Justin Ash purchased 21,100 shares of Spire Healthcare Group stock in a transaction on Tuesday, September 17th. The stock was bought at an average cost of GBX 236 ($3.01) per share, with a total value of £49,796 ($63,426.32). Insiders own 34.71% of the company’s stock.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.